Announcements Trials

Browse Landscape

Phase

Status

Completed 6 Recruiting 4 Terminated 2 Not yet recruiting 2 Active not recruiting 2 Unknown 1 Suspended 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Large B-Cell, Diffuse 25 Lymphoma 24 Precursor Cell Lymphoblastic Leukemia-Lymphoma 19 Leukemia 11 Neuroblastoma 10 Lymphoma, Non-Hodgkin 10 Central Nervous System Neoplasms 8 Lymphoma, Follicular 6 Hodgkin Disease 6 Sarcoma 5 Retinoblastoma 5 Lymphoma, T-Cell, Peripheral 5 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4 Lymphoma, Mantle-Cell 4 Immunoblastic Lymphadenopathy 4 Wilms Tumor 3 Oligodendroglioma 3 Lymphoma, Large-Cell, Immunoblastic 3 Lymphoma, Large-Cell, Anaplastic 3 Kidney Neoplasms 3 Burkitt Lymphoma 3 Astrocytoma 3 Recurrence 2 Neuroectodermal Tumors, Primitive, Peripheral 2 Neoplasms, Plasma Cell 2 Neoplasms 2 Multiple Myeloma 2 Leukemia, T-Cell 2 Leukemia, Biphenotypic, Acute 2 Enteropathy-Associated T-Cell Lymphoma 2

Interventions

Cyclophosphamide 3 seclidemstat 2 Topotecan 2 Drug Therapy 2 irinotecan sucrosofate 1 anlotinib 1 Vinorelbine 1 Vincristine 1 Triptorelin Pamoate 1 Trabectedin 1 Temozolomide 1 TQ-B3525 1 Microbiota 1 Metabolome 1 Irinotecan 1 IVA protocol 1 Biological Factors 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Sarcoma, Ewing × Vincristine × Clear all

NCT03359005 2022-11-01

Irinotecan and Temozolomide for Ewing Sarcoma

Peking University People's Hospital

Phase 2 Unknown

Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon ⚡